ライフサイエンスコーパス: transferrin receptor

1 screened, including CD54 (ICAM-1) and CD71 (transferrin receptor).

2 tinol-binding protein (vitamin A), and iron (transferrin receptor).

3 ue and change in plasma ferritin and soluble transferrin receptor.

4 curium-transferrin complexes by the cognate transferrin receptor.

5 d with clathrin and the IR, but not with the transferrin receptor.

6 cycling endosomes positive for Rab11 and the transferrin receptor.

7 cling endosomes, where it interacts with the transferrin receptor.

8 calization of CD44 with the nonraft protein, transferrin receptor.

9 mal markers, but showed coincidence with the transferrin receptor.

10 a non-ER resident type II protein, the human transferrin receptor.

11 with a monoclonal antibody against the mouse transferrin receptor.

12 nds on transferrin-bound iron uptake via the transferrin receptor.

13 were observed for serum ferritin and soluble transferrin receptor.

14 r (CIMPR) without affecting that of TGN46 or transferrin receptor.

15 ermined from hemoglobin, serum ferritin, and transferrin receptor.

16 red in the recycling pathway of the exocytic transferrin receptor.

17 eceptor, while New World arenaviruses hijack transferrin receptor.

18 ed for hemoglobin, serum ferritin, and serum transferrin receptor.

19 nsferrin uptake and lysosomal degradation of transferrin receptors.

20 stitution impairs the endocytic recycling of transferrin receptors.

21 lex class I-like protein that interacts with transferrin receptors.

22 MPO was associated with a lower risk of high transferrin receptor [0.86 (0.74, 0.98)], NEO with a low

23 Human transferrin receptor 1 (CD71) guarantees iron supply by

24 However, the role of transferrin receptor 1 (CD71)-expressing AMs in IPF is n

25 gested that circulating levels of shed human transferrin receptor 1 (hTfR1) are regulated by PC7.

26 These NWAs use human transferrin receptor 1 (hTfR1) as a host cell receptor f

27 viral hemorrhagic fever is the use of human transferrin receptor 1 (hTfR1) for cellular entry.

28 PC7 sheds human transferrin receptor 1 (hTfR1) into soluble shTfR1 in en

29 iptionally regulates the iron-uptake protein transferrin receptor 1 (TfR1) and the iron-storage prote

30 enic arenaviruses from South America utilize transferrin receptor 1 (TfR1) as a cellular receptor, th

31 Each uses human transferrin receptor 1 (TfR1) as its obligate receptor.

32 ates entry into grivet and bat cells through transferrin receptor 1 (TfR1) binding but that OCEV glyc

33 Transferrin receptor 1 (Tfr1) facilitates cellular iron

34 Upregulation of transferrin receptor 1 (TfR1) in brain microvasculature

35 ptide ligase, butelase 1, to label the human transferrin receptor 1 (TfR1) in established human cell

36 Transferrin receptor 1 (TfR1) is a ubiquitous type II me

37 Overexpression of transferrin receptor 1 (TFR1) is common across cancer an

38 Transferrin receptor 1 (TfR1) mediated transcytosis is a

39 Transferrin receptor 1 (Tfr1) mediates uptake of circula

40 thogenic arenaviruses of the same clade, use transferrin receptor 1 (TfR1) of their host species to e

41 CF macrophage transferrin receptor 1 (TfR1) was reduced with ivacaftor

42 igh affinity single domain antibodies to the transferrin receptor 1 (TfR1) with efficient biotherapeu

43 rophic receptors and cognate ligands such as transferrin receptor 1 (TfR1), but not TfR2.

44 had a homozygous p.Tyr20His substitution in transferrin receptor 1 (TfR1), encoded by TFRC.

45 T1), the ferritin heavy chain (Fth), and the transferrin receptor 1 (Tfr1), were postnatally ablated

46 The antibody engages the GP1 site that binds transferrin receptor 1 (TfR1)-the host cell surface rece

47 iated with the placental nonheme Fe importer transferrin receptor 1 (TfR1).

48 ated with decreased ferritin H and increased transferrin receptor 1 (TfR1).

49 lters expression of the iron uptake receptor transferrin receptor 1 (TfR1).

50 lating iron homeostasis via interacting with transferrin receptor 1 (TFR1).

51 F)-bound iron by modulating the synthesis of transferrin receptor 1 (TfR1).

52 GPC architecture and share a host receptor, transferrin receptor 1 (TfR1).

53 he metabolite stearic acid (C18:0) and human transferrin receptor 1 (TFR1; also known as TFRC) as mit

54 tomography (PET) radiotracer that binds the transferrin receptor 1 (TFRC, CD71) with high avidity.

55 restricted to reticulocytes expressing both transferrin receptor 1 (Trf1 or CD71) and the Duffy anti

56 ransporters mediating placental iron uptake (transferrin receptor 1 [TFR1]) and export (ferroportin [

57 l iron pools and increased the expression of transferrin receptor 1 and iron regulatory protein 2 con

58 were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the

59 k has demonstrated the requirement for human transferrin receptor 1 for virus entry, and the absence

60 IRP2 RNA binding is correlated with reduced transferrin receptor 1 mRNA abundance.

61 Iron-loaded transferrin binds to transferrin receptor 1 on the surface of most body cells

62 rom transferrin without increasing levels of transferrin receptor 1 or the uptake of transferrin.

63 pathogenic New World arenaviruses use human transferrin receptor 1 to enter cells.

64 ession of the mesangial IgA1 receptor, TfR1 (transferrin receptor 1).

65 ion of the divalent metal transporter 1, the transferrin receptor 1, and the ferritin heavy chain in

66 We demonstrate that loss of transferrin receptor 1, but not loss of ferroportin, can

67 However, loss of transferrin receptor 1, involved in iron uptake, caused

68 rived cell lines through a low-pH-dependent, transferrin receptor 1-independent mechanism, suggesting

69 ed for iron homeostasis such as ferritin and transferrin receptor 1.

70 Hepatic levels of transferrin receptors 1 and 2 and ZRT/IRT-like protein 1

71 sing expression cloning, we identified human transferrin receptor-1 (TfR1) as an important receptor f

72 rristatin (NSC30611) acts by down-regulating transferrin receptor-1 (TfR1) via receptor degradation.

73 sion of hepcidin and increased expression of transferrin receptor-1 and erythroferrone, suggesting th

74 egulates iron homeostasis components such as transferrin receptor-1 and ferritin-H in hepatic and ske

75 n-responsive elements present in the UTRs of transferrin receptor-1 and ferritin-H transcripts.

76 iron-responsive elements present in UTRs of transferrin receptor-1 and ferritin-H.

77 , divalent metal transporter-1, ferritin and transferrin receptor-1 and greater accumulation of iron.

78 brain is >10-fold greater than antibodies to transferrin receptor-1 and intercellular adhesion molecu

79 fectively depleted cellular Fe, resulting in transferrin receptor-1 up-regulation, ferritin down-regu

80 Increased transferrin receptor-1, decreased ferritin-H, and increa

81 specifically with its cell-surface receptor transferrin receptor-1.

82 HFE and transferrin receptor 2 (TFR2) are each necessary for the

83 Mutations in transferrin receptor 2 (TfR2) cause a rare form of the h

84 utations in hemochromatosis protein (HFE) or transferrin receptor 2 (TFR2) cause hereditary hemochrom

85 Transferrin receptor 2 (TFR2) contributes to hepcidin re

86 Transplanting TM1 into transferrin receptor 2 (TfR2) induces Golgi accumulation

87 Transferrin receptor 2 (TFR2) is a transmembrane protein

88 Mutations in HFE, transferrin receptor 2 (Tfr2), hemojuvelin (HJV), or bon

89 regulatory genes, hemochromatosis (Hfe) and transferrin receptor 2 (Tfr2).

90 administration or modulating the ability of transferrin receptor 2 [Tfr2] to control red blood cell

91 hereditary hemochromatosis proteins HFE and transferrin receptor 2 may intersect with the BMP pathwa

92 n), HFE (hemochromatosis protein), and TfR2 (transferrin receptor 2), these proteins do not control t

93 and Mk-biased commitment after knockdown of transferrin receptor 2, a putative iron sensor.

94 (BMP6), hereditary hemochromatosis protein, transferrin receptor 2, matriptase-2, neogenin, BMP rece

95 he hereditary hemochromatosis protein (HFE), transferrin-receptor 2 (TfR2), hemojuvelin, hepcidin, or

96 iron, including HFE and, in rarer instances, transferrin-receptor 2 and hemojuvelin, or make its rece

97 Hemojuvelin (HJV), HFE, and transferrin receptor-2 (TfR2) facilitate this process pr

98 s been associated with mutations in the HFE, transferrin receptor-2 (TfR2), and hemojuvelin (HJV) gen

99 nclude newly identified interactions between transferrin receptor-2 and the erythropoietin receptor.

100 nosome genome contains a family of around 14 transferrin receptors(4), which has been proposed to all

101 .006), a lower mean concentration of soluble transferrin receptor (6.1 compared with 7.8 mg/L, P = 0.

102 tes cellular iron uptake by interacting with transferrin receptor, a crucial protein during erythropo

103 ovary cells with a GFP-tagged transmembrane transferrin receptor, a well-known benchmark of membrane

104 Expression of transferrin receptor and 24p3R were reduced in tubules f

105 M images identified < or =200 nm clusters of transferrin receptor and clathrin light chain at < or =2

106 nin virus (JUNV) failed to down-regulate the transferrin receptor and did not induce superinfection e

107 determined that CSCs preferentially require transferrin receptor and ferritin, two core iron regulat

108 tamate, and stabilizes surface expression of transferrin receptor and GLAST transporter.

109 brogates the somatodendritic polarity of the transferrin receptor and several glutamate receptor type

110 lathrin-mediated internalization of both the transferrin receptor and the beta2 adrenergic receptor.

111 We further found that the cell surface transferrin receptor and the glutamine-fueled intracellu

112 teractions between the basolateral signal of transferrin receptor and the medium subunits of both AP-

113 s) target cerebral endothelial cells through transferrin receptor and the receptor for advanced glyca

114 eceptors and plasma membrane lipids, such as transferrin receptors and sphingomyelin, are delivered t

115 interleukin 2 receptor alpha subunit or Tac, transferrin receptor, and cluster of differentiation 8a,

116 l recycling endosomes positive for Rab11 and transferrin receptor, and CvpA membrane interactions wer

117 alysis was used to determine the presence of transferrin receptor, and ELISA was used to determine to

118 n the aged RPE/choroid, whereas transferrin, transferrin receptor, and ferroportin mRNAs did not chan

119 Serum ferritin, serum transferrin receptor, and hemoglobin concentrations were

120 coexpressing Dendra2-hemagglutinin, PAmKate-transferrin receptor, and PAmCherry1-beta-actin fusion c

121 on and vitamin A biomarkers (ferritin, serum transferrin receptor, and retinol binding protein) in se

122 e binding partners of these deposits (sCD89, transferrin receptor, and transglutaminase 2) decreased

123 ritin, transferrin saturation, serum soluble transferrin receptors, and the serum soluble transferrin

124 ndosomes co-localized with subsets of Rab5-, transferrin receptor-, and Lamp1/Lysotracker-marked comp

125 i-intracellular adhesion molecule 1 and anti-transferrin receptor antibodies.

126 = 200 nm, height (h) = 200 nm) labeled with transferrin receptor antibody (NP-OKT9) or human transfe

127 ake of therapeutically relevant transferrin, transferrin receptor antibody and plasma.

128 nhibit receptor activity simultaneously; and transferrin receptor antibody, to target the tumor vascu

129 leaves unchanged the rate by which MC4R and transferrin receptor are constitutively excluded from th

130 constitutively recycled, HSP90-independent, transferrin receptor are found within modified endosomes

131 We found that transferrin receptors are delivered selectively from cla

132 rin uptake is due to a decrease in available transferrin receptor at the cell surface, and not to a s

133 in uptake in mitosis occurs despite abundant transferrin receptor at the surface of HeLa cells.

134 approach using expression of a biotinylated transferrin receptor (bTfnR) and controlling its local c

135 ith the endosomal markers including EEA1 and transferrin receptors but also with the TGN marker synta

136 ers and found that the TM motifs of CD40 and transferrin receptor, but not that of CD45, could functi

137 rine brain endothelioma cells overexpressing transferrin receptors, by about 1.4-fold and 2.3-fold co

138 (Tf) and evaluate the ability of the natural transferrin receptor CD71 to modulate immunity.

139 l precursors that can be graded by levels of transferrin receptor (CD71) expression.

140 ulating red blood cells were found to retain transferrin receptor (CD71) in their membrane, demonstra

141 The transferrin receptor (CD71) is up-regulated in duodenal

142 /proerythroblast stage, a point at which the transferrin receptor (CD71) is upregulated, iron is impo

143 owever, the selective tropism of P vivax for transferrin receptor (CD71)-positive reticulocytes remai

144 surface of HeLa cells and inhibited LDLR and transferrin receptor clustering.

145 anism to induce transport of the transferrin/transferrin receptor complex across the BBB.

146 n calculated from serum ferritin and soluble transferrin receptor concentrations allows for the evalu

147 e calculated from serum ferritin and soluble transferrin receptor concentrations, can be used to asse

148 cality of current biomarkers such as soluble transferrin-receptor concentrations and others, and caus

149 ing spreading, but endoplasmic reticulum and transferrin receptor-containing vesicles are not.

150 otocol makes use of cargo protein (e.g., the transferrin receptor) coupled to a pH-sensitive fluoresc

151 creased early in flight, and transferrin and transferrin receptors decreased later, which indicated t

152 which stalled transit of a1 and transferrin-transferrin receptor, decreased proton efflux, and reduc

153 not contacting transferrin, suggesting that transferrin receptor diversification is driven by a need

154 pe SH3TC2, but not mutant SH3TC2, influences transferrin receptor dynamics, consistent with a functio

155 CD4, the asialoglycoprotein receptor, or the transferrin receptor eliminates intramembrane proteolysi

156 rformed PALM imaging using PAmCherry1-tagged transferrin receptor expressed alone or with photoactiva

157 This was reflected in increased transferrin receptor expression and increased splenic ir

158 ginase-1 and YM1 transcription and increased transferrin receptor expression by phagocytic cells.

159 Furthermore, the decrease in transferrin receptor expression in the microvasculature

160 oehner et al. (2014) describe a modular anti-transferrin receptor Fab approach for shuttling therapeu

161 d levels of ferritin and increased levels of transferrin receptor, features characteristic of cellula

162 transferrin receptors, and the serum soluble transferrin receptors-ferritin index are more accurate t

163 ron can effectively reach the brain by using transferrin receptors for crossing the blood-brain barri

164 tures, known mediators of rapid recycling of transferrin receptor from endosomes.

165 that mislocalize the dendritic marker human transferrin receptor (hTfR), we found that kinesin heavy

166 nt glycoprotein, GP1, and cell surface human transferrin receptor (hTfR1).

167 Consistent with this, there was stronger transferrin receptor immunoreactivity in the light-expos

168 rmined the structure of a Trypanosoma brucei transferrin receptor in complex with human transferrin,

169 uent delivery into cancer cells, mediated by transferrin receptors, in a complex biological matrix.

170 the protein level, decreased transferrin and transferrin receptor, increased ferritin and ceruloplasm

171 ical early endosomal recycling receptor, the transferrin receptor, indicating that this viral protein

172 pid stress disrupted later steps of MC4R and transferrin receptor internalization to endosomes as wel

173 ugh integrin beta1 endocytosis was impaired, transferrin receptor internalization was unaffected.

174 rrin receptor recycling but has no effect on transferrin receptor internalization.

175 e for Rabenosyn-5 in determining the fate of transferrin receptors internalized by clathrin-mediated

176 e for the first time that endocytosis of the transferrin receptor is a regulated process that require

177 ereas the CME of constitutively internalized transferrin receptors is mainly dependent on the ubiquit

178 tus (ferritin level, transferrin saturation, transferrin receptor level, reticulocyte hemoglobin leve

179 iron availability, as noted by a decrease in transferrin receptor levels and iron uptake from transfe

180 nd decreased expression of the iron importer transferrin receptor, likely reflecting a regulatory res

181 ) and negatively correlated with the soluble transferrin receptor/log(ferritin) ratio but not correla

182 c characterization, these studies prove that transferrin receptor-mediated endocytosis is a viable me

183 f zinc finger nucleases (ZFN) proteins using transferrin receptor-mediated endocytosis.

184 ize, low cellular toxicity and the efficient transferrin receptor-mediated uptake render the AspA tag

185 Anti-transferrin receptor monoclonal antibody (OX26)-PEGylate

186 Transferrin receptor mRNA (Tfrc), an indicator of iron l

187 Moreover, quantification of transferrin receptor mRNA in single cells agrees well wi

188 Type 1 transferrin receptor mRNA was unexpectedly decreased in

189 Transferrin receptor mRNA, which contains two highly con

190 posomal preparation was also targeted to the transferrin receptor of cancer cells by modifying the su

191 >/=1 biomarker of iron [ferritin or soluble transferrin receptor or vitamin A status (retinol-bindin

192 on hemoglobin, serum ferritin (SF), soluble transferrin receptor, or body iron was conducted.

193 stricted to this membrane cargo, however, as transferrin receptors packaged in the same population of

194 nnose glycosylation at the helical domain of transferrin receptor protein 1 promotes conformational c

195 chlamydial growth and replication, including transferrin receptor protein 1, the amino acid transport

196 NA 2.7-fold after 11 days and also increased transferrin receptor protein.

197 0.22; beta = -0.17 (95% CI: -0.25, -0.09)], transferrin receptor [R(2) = 0.23; beta = 2.79 (95% CI:

198 activating protein for Rab4A that regulates transferrin receptor recycling and EGFR trafficking and

199 , but not the inactive R494A mutant, reduces transferrin receptor recycling but has no effect on tran

200 ation of Bves function specifically inhibits transferrin receptor recycling, and results in gastrulat

201 the modified CLC reduces beta1-integrin and transferrin receptor recycling, as well as cell migratio

202 ing complex pathway, its knockdown arresting transferrin receptor recycling.

203 nd AP2-dependent cargoes, integrin beta1 and transferrin receptor, respectively.

204 cysteines 556 and 558 on the surface of the transferrin receptor resulting in subsequent endocytic u

205 biomarkers including serum ferritin, soluble transferrin receptor, retinol-binding protein (RBP), 25-

206 Maternal hemoglobin, ferritin, transferrin receptors, retinol binding protein (RBP), zi

207 were internalized to a greater extent by the transferrin-receptor-rich DU-145 cells.

208 ed concentrations of erythropoietin, soluble transferrin receptor (sCD71), and thrombopoietin.

209 ators serum ferritin <15 ug/L, serum soluble transferrin receptor (sTfR) >4.4 mg/L, and calculated to

210 that is calculated from ferritin and soluble transferrin receptor (sTfR) allows for the evaluation of

211 < or = 0.05), and concentrations of soluble transferrin receptor (sTfR) and hemoglobin and the red c

212 ons.We assessed the relation between soluble transferrin receptor (sTfR) concentrations and inflammat

213 = 0.04) and France (P = 0.04) and on soluble transferrin receptor (sTfR) for participants in Poland (

214 serum ferritin decreased (P < 0.0001), serum transferrin receptor (sTfR) increased (P < 0.0001), and

215 Soluble transferrin receptor (sTfR) is thought to be unaffected

216 n, ferritin, C-reactive protein, and soluble transferrin receptor (sTfR) strongly predicted incorpora

217 wich assay (SA) for the detection of soluble transferrin receptor (sTfR), a biomarker of IDA, on a ph

218 time, measured by sFer, hemoglobin, soluble transferrin receptor (sTfR), and estimated total body ir

219 ir relations with serum ferritin (SF), serum transferrin receptor (sTfR), and hemoglobin.

220 rically to include plasma ferritin), soluble transferrin receptor (sTfR), and total body iron (TBI) w

221 line hemoglobin, ferritin, hepcidin, soluble transferrin receptor (sTfR), and transferrin were measur

222 in (SF), transferrin saturation, and soluble transferrin receptor (sTfR), as well as erythrocyte prot

223 timated on the basis of plasma iron, soluble transferrin receptor (sTfR), ferritin, transferrin, tran

224 ess hemoglobin, serum ferritin (SF), soluble transferrin receptor (sTfR), hepcidin, serum iron, eryth

225 iciency, defined by raised levels of soluble transferrin receptor (sTfR), was investigated in 98 pati

226 ) (B = -0.17), hepcidin (B = -0.36), soluble transferrin receptor (sTfR; B = 0.33), and EPO (B = 0.28

227 However, variation in hepcidin, soluble transferrin receptors (sTfR), and hemoglobin/anemia was

228 P]) and biomarkers of MN status (pF, soluble transferrin receptor [sTfR], RBP, and pZn), and compare

229 Similar results are found for transferrin receptor, suggesting a general mechanism of

230 r trafficking of the endogenously expressing transferrin receptor, suggesting ethanol does not have a

231 followed an innovative approach of combining transferrin receptor targeting with enhanced cell penetr

232 epidermal growth factor receptor (EGFR) and transferrin receptor (TfnR) exhibited changes in steady-

233 e found that Arf6 colocalized with AP-1B and transferrin receptor (TfnR) in REs.

234 duodenal cytochrome b (Dcytb) 1.8-fold, and transferrin receptor (TfR) 1.8-fold.

235 t external cues induced up-regulation of the transferrin receptor (TfR) and down-regulation of ferrit

236 ealed differences in the dynamic behavior of Transferrin Receptor (TfR) and Langerin proteins.

237 tosis, plasma membrane receptors such as the transferrin receptor (TfR) are internalized by a caveola

238 a, low retinol, zinc, and ferritin, and high transferrin receptor (TfR) at 15 mo.

239 The P2Ns manifest transferrin receptor (TfR) colocalization in ex vivo int

240 res and impairs recycling of the transferrin-transferrin receptor (TfR) complex to the plasma membran

241 Antibodies to transferrin receptor (TfR) have potential use for therap

242 Our results identify a role for PICALM in transferrin receptor (TfR) internalization and demonstra

243 Increased surface expression of transferrin receptor (TfR) is a downstream event of MYC

244 Transferrin receptor (TFR) is an important iron transpor

245 te of iron acquisition in vertebrates is the transferrin receptor (TfR) mediated endocytotic pathway,

246 iron ions which are delivered to cells in a transferrin receptor (TFR) mediated process.

247 The transferrin receptor (TfR) of the bloodstream form (BSF)

248 (hTF) molecules to the specific homodimeric transferrin receptor (TFR) on the cell surface.

249 rom raccoons do not efficiently bind the dog transferrin receptor (TfR) or infect dog cells, a single

250 We have investigated the transferrin receptor (TfR) pathway, which is not only es

251 Transferrin receptor (TfR) represents a unique target fo

252 target a protein complex of transferrin and transferrin receptor (TfR) through a non-canonical allos

253 in the form of tunable nanosystems (NS) for transferrin receptor (TfR) utilizing gambogic acid (GA),

254 , and utilization of a CDP that binds to the transferrin receptor (TfR), a native receptor and BBB tr

255 monoclonal antibody (MAb) against the mouse transferrin receptor (TfR), and these fusion proteins ar

256 monoclonal antibody (MAb) against the mouse transferrin receptor (TfR), and this fusion protein is d

257 Both viruses bind their host transferrin receptor (TfR), enter cells by clathrin-medi

258 Similar to the constitutive endocytosis of transferrin receptor (TfR), ligand- triggered endocytosi

259 g because of the active participation of the transferrin receptor (TFR), salt, a chelator, lobe-lobe

260 t epithelia to relocate AP-1B cargo, such as transferrin receptor (TfR), to the apical PM.

261 monoclonal antibody (MAb) against the mouse transferrin receptor (TfR), which is designated as the c

262 monoclonal antibody (MAb) against the mouse transferrin receptor (TfR), which is designated the cTfR

263 NHE5 is associated with transferrin receptor (TfR)- and Rab11-positive recycling

264 conditions, as well as their ability to bind transferrin receptor (TfR).

265 fect on the clathrin-mediated endocytosis of transferrin receptor (TfR).

266 Transferrin receptor (TfR, CD71) has long been a therape

267 of 3 abnormal ferritin (< 12 mug/L), soluble transferrin receptor (TfR; > 8.3 mg/L), or zinc protopor

268 anine parvovirus (CPV) capsids with cellular transferrin receptors (TfR) on the surfaces of live feli

269 ptake of systemically dosed antibodies (anti-transferrin receptor [TfR] bispecific versus control ant

270 nd significance of positive selection on the transferrin receptor TfR1, a housekeeping protein requir

271 The posttranslational regulation of transferrin receptor (TfR1) is largely unknown.

272 Transferrin Receptor (TfR1) is the cell-surface receptor

273 consequence, IRP1 target genes, such as the transferrin receptor (TfR1), a membrane-associated glyco

274 PN), the iron efflux pump, is decreased, and transferrin receptor (TFR1), the iron importer, is incre

275 transmembrane protease, serine 6 (TMPRSS6), transferrin receptor (TFR2), N-acetyltransferase 2 (aryl

276 biquitin C (UBC) in head and neck cancer and Transferrin receptor (TFRC) and beta-Glucuronidase (GUSB

277 y recognized CPV host-to different carnivore transferrin receptors (TfRs) using single-particle track

278 ed in dynamin-dependent endosomes labeled by transferrin receptors (TfRs).

279 nce of the transferrin moiety binding to the transferrin receptor, the activated ProINS-Tf exhibited

280 Consistently, expression of transferrin receptor, the brain's main iron-influx prote

281 0 mg/kg and calculated from the log ratio of transferrin receptor to ferritin (the body iron model) t

282 carnivores due to its interactions with the transferrin receptor to mediate infection.

283 both Rab11 and the constitutively recycling transferrin receptor to the periphery of cells.

284 d an increased dependence of Cd1 GP on human transferrin receptor type 1 (hTfR-1) for entry, which ma

285 ized by different abilities to use the human transferrin receptor type 1 (hTfR1) protein as a recepto

286 ve feline panleukopenia virus (FPV) bind the transferrin receptor type 1 (TfR) to infect their host c

287 300Lys) altered the binding of the capsid to transferrin receptor type 1 (TfR), particularly during v

288 mutations that allowed binding to the canine transferrin receptor type 1 (TfR).

289 ecies-specific binding to the host receptor, transferrin receptor type-1 (TfR).

290 ization of beta1 integrins without affecting transferrin receptor uptake.

291 ytosis and coincided with the recruitment of transferrin receptor, VAMP3, and dynamin-2.

292 Transferrin receptor was positively related to HAZ (0.18

293 umours respect to surrounding liver, whereas transferrin receptor was up-regulated.

294 For example, the transferrin receptor was upregulated in both light-expos

295 rtantly, the constitutive internalization of transferrin receptors was unaffected by either treatment

296 ed blood cell distribution width and soluble transferrin receptor were elevated (P < 0.05), and serum

297 status biomarkers (ie, ferritin and soluble transferrin receptor) were significantly associated with

298 points, internalized GPR17 co-localized with transferrin receptor, whereas at later times it partiall

299 DNA damage, p53 induced FTH1 and suppressed transferrin receptor, which regulates iron entry into ce

300 tress, including a failure to upregulate the transferrin receptor, which we show is a novel stress ta